The Metabolic Switch that Forges an Antibody Factory
A study in the Journal of Experimental Medicine reveals the precise molecular and metabolic reprogramming required for B cells in the germinal center to become antibody-secreting plasma cells. Researchers identified CD205 as a marker for pre-plasma cells in both mice and humans. They found that the enzyme Kdm6b, which removes repressive epigenetic marks, is essential for this final differentiation step. Intriguingly, these pre-plasma cells ramp up glutamine metabolism to produce α-ketoglutarate, a necessary co-factor for Kdm6b’s activity, directly linking cellular fuel to the epigenetic control of antibody production.
Why it might matter to you:
This work provides a mechanistic blueprint for how the immune system generates high-quality antibodies, a process central to vaccine efficacy. Understanding the metabolic-epigenetic axis controlling plasma cell fate could inform strategies to enhance B-cell therapies or modulate humoral immunity. For researchers investigating cell differentiation or transplantation, it highlights how fundamental metabolic pathways can be co-opted to direct specific functional outcomes in immune cells.
Stay curious. Stay informed — with
Science Briefing.
Always double check the original article for accuracy.
